2. Within the past 12 months, I have had financial relationships with commercial interests, manufacturers, and/or
proprietary entities. Please check the following relationships, which will be disclosed to the audience are:
Speaker’s
Commercial Interest
Research
Employee
Board
Stock/
Consultant
Other
Received monies
(Name of Company)
Support
Bureau
Member/
Shareholder
greater than
Advisory Panel
$10, 000 per
company
Explain “Other” Relationship ________________________________________________________________________________
3. In my role with this activity, I agree to abide by the following Content Validation Statements with regard to any
recommendations for clinical care:
All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as
adequate justification for their indications and contraindications in the care of patients; AND/OR
All scientific research referred to or reported in support or justification of a patient care recommendation conforms to
generally accepted standards of experimental design, data collection, and analysis.
4. In my role with this activity, I will ensure that my presentation will be independent, balanced, objective and
scientifically rigorous.
5. I agree to abide by the standards of commercial support guidelines in that my poster presentation will ONLY
include generic names of drugs and not include use of company names/logos.
6. I agree that my presentation will address at least one of the IOM or ACGME/ABMS core competencies.
____________________________________________
_______________________
SIGNATURE
DATE
A separate disclosure form must be completed by ALL authors and returned to:
Shirley Ash, American Diabetes Association, 2451 Crystal Drive, Suite 900, Arlington, VA 22202
Phone: 703-549-1500, x2214 Fax: 703-253-4358 E-mail: